Related references
Note: Only part of the references are listed.Absolute Lymphocyte Count After COVID-19 Vaccination Is Associated with Vaccine-Induced Hypermetabolic Lymph Nodes on 18F-FDG PET/CT: A Focus in Breast Cancer Care
Romain-David Seban et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
COVID-19 mRNA Vaccination: Age and Immune Status and Its Association with Axillary Lymph Node PET/CT Uptake
Michal Eifer et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
DOTATATE Uptake in an Axillary Lymph Node After COVID-19 Vaccination
James Brophy et al.
CLINICAL NUCLEAR MEDICINE (2022)
[18F]FDG uptake of axillary lymph nodes after COVID-19 vaccination in oncological PET/CT: frequency, intensity, and potential clinical impact
Stephan Skawran et al.
EUROPEAN RADIOLOGY (2022)
Vaccine-Related Lymph Nodes The Emerging Pitfalls of 18F-Fluorocholine and 68Ga-PSMA-11 PET/CT in the Era of COVID-19 Vaccination
Loic Ah-Thiane et al.
CLINICAL NUCLEAR MEDICINE (2022)
Novel68Ga-FAPI PET/CT offers oncologic staging without COVID-19 vaccine-related pitfalls
Tristan T. Demmert et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Recent topics of the clinical utility of PET/MRI in oncology and neuroscience
Yuji Nakamoto et al.
ANNALS OF NUCLEAR MEDICINE (2022)
Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality
T. J. A. van Nijnatten et al.
EUROPEAN JOURNAL OF RADIOLOGY (2022)
Hypermetabolic Ipsilateral Supraclavicular and Axillary Lymphadenopathy: Optimal Time Point for Performing an 18F-FDG PET/CT after COVID-19 Vaccination
Kwadwo Antwi et al.
DIAGNOSTICS (2022)
FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study
Michal Eifer et al.
EUROPEAN RADIOLOGY (2022)
COVID-19 vaccine-related unilateral axillary lymphadenopathy: Pattern on screening breast MRI allowing for a benign assessment
Michael J. Plaza et al.
CLINICAL IMAGING (2021)
COVID-19 vaccination induced axillary nodal uptake on [18F]FDG PET/CT
Ayah Adel Nawwar et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Imaging of COVID-19 Vaccination at FDG PET/CT
Michal Eifer et al.
RADIOLOGY (2021)
Frequency and Characteristics of Nodal and Deltoid FDG and 11C-Choline Uptake on PET Performed After COVID-19 Vaccination
Dane G. Schroeder et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2021)
Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG PET-CT and relevance to study interpretation
Dan Cohen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination
Yael Eshet et al.
RADIOLOGY (2021)
Immune Response Visualized In Vivo by [18F]-FDG PET/CT after COVID-19 Vaccine
Romain-David Seban et al.
DIAGNOSTICS (2021)
Contralateral Axillary Lymph Node Metastases from Breast Carcinoma: Is it Time to Review TNM Cancer Staging?
Francesca Magnoni et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Comparison of diagnostic sensitivity of [18F]fluoroestradiol and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for breast cancer recurrence in patients with a history of estrogen receptor-positive primary breast cancer
Sun Young Chae et al.
EJNMMI RESEARCH (2020)
18F-Fluoroestradiol PET/CT Correctly Diagnosed 18F-FDG-Avid Inflammatory Lymph Nodes in a Patient With Estrogen Receptor-Positive Breast Cancer
Tomohiko Yamane et al.
CLINICAL NUCLEAR MEDICINE (2018)
Contralateral axillary lymph node metastasis in second primary Breast cancer: Case report and review of the literature
Jacob Gingerich et al.
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2017)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Fluoroestradiol Positron Emission Tomography Reveals Differences in Pharmacodynamics of Aromatase Inhibitors, Tamoxifen, and Fulvestrant in Patients with Metastatic Breast Cancer
Hannah M. Linden et al.
CLINICAL CANCER RESEARCH (2011)
Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer
Hannah M. Linden et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)